MET Genomic Alterations in Head and Neck Squamous Cell Carcinoma (HNSCC): Rapid Response to Crizotinib in a Patient with HNSCC with a Novel MET R1004G Mutation

作者
Lisa Pei Chu,Debra Franck,Christine A. Parachoniak,Jeffrey P. Gregg,Michael G. Moore,Donald Gregory Farwell,Shyam S. D. Rao,Andreas M. F. Heilmann,Rachel Erlich,Jeffrey S. Ross,Vincent A. Miller,Siraj Mahamed Ali,Jonathan Wesley Riess
出处
期刊:Oncologist [AlphaMed Press]
卷期号:24 (10): 1305-1308 被引量:9
标识
DOI:10.1634/theoncologist.2019-0230
摘要

Abstract Identification of effective targeted therapies for recurrent/metastatic head and neck squamous cell carcinoma (HNSCC) remains an unmet medical need. A patient with platinum-refractory recurrent oral cavity HNSCC underwent comprehensive genomic profiling (CGP) that identified an activating MET mutation (R1004). The patient was treated with the oral MET tyrosine kinase inhibitor crizotinib with rapid response to treatment. Based on this index case, we determined the frequency of MET alterations in 1,637 HNSCC samples, which had been analyzed with hybrid capture-based CGP performed in the routine course of clinical care. The specimens were sequenced to a median depth of >500× for all coding exons from 182 (version 1, n = 24), 236 (version 2, n = 326), or 315 (version 3, n = 1,287) cancer-related genes, plus select introns from 14 (version 1), 19 (version 2), or 28 (version 3) genes frequently rearranged in cancer. We identified 13 HNSCC cases (0.79%) with MET alterations (4 point mutation events and 9 focal amplification events). MET-mutant or amplified tumors represent a small but potentially actionable molecular subset of HNSCC. Key Points This case report is believed to be the first reported pan-cancer case of a patient harboring a MET mutation at R1004 demonstrating a clinical response to crizotinib, in addition to the first documented case of head and neck squamous cell carcinoma (HNSCC) with any MET alteration responding to crizotinib. The positive response to MET inhibition in this patient highlights the significance of comprehensive genomic profiling in advanced metastatic HNSCC to identify actionable targetable molecular alterations as current treatment options are limited.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
吃饭饭发布了新的文献求助10
刚刚
Kare完成签到,获得积分10
1秒前
1秒前
1111发布了新的文献求助10
1秒前
酷酷的丝袜完成签到 ,获得积分20
2秒前
班小班完成签到,获得积分10
2秒前
wan完成签到 ,获得积分10
2秒前
2秒前
2秒前
2秒前
小象发布了新的文献求助10
3秒前
高沅发布了新的文献求助10
3秒前
dou发布了新的文献求助30
3秒前
那年夏天完成签到,获得积分10
4秒前
4秒前
CodeCraft的应助被xiaomu采纳,获得10
5秒前
酷波er的应助被老橡树采纳,获得20
5秒前
LLL发布了新的文献求助10
5秒前
6秒前
TiAmo完成签到 ,获得积分10
8秒前
8秒前
8秒前
yy发布了新的文献求助10
9秒前
9秒前
cailiao完成签到,获得积分10
9秒前
StarletZhou完成签到,获得积分10
10秒前
怪奇物语完成签到,获得积分10
11秒前
11秒前
howdream发布了新的文献求助10
11秒前
小象完成签到,获得积分10
11秒前
11秒前
皮卡皮卡丘完成签到,获得积分10
12秒前
乐乐的应助被环游世界采纳,获得10
12秒前
dinghongmei发布了新的文献求助10
13秒前
tianxiao发布了新的文献求助10
13秒前
哈哈完成签到,获得积分10
13秒前
1111完成签到,获得积分10
13秒前
贪玩翅膀发布了新的文献求助80
14秒前
molihuakai的应助被陈明采纳,获得10
14秒前
ly完成签到,获得积分10
14秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1500
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology)求助 1000
Encyclopedia of Modern Artificial Intelligence 1000
John McDowells Bildungstheorie 800
Analyses de reconnaissances de dettes passées devant les échevins d'Ypres (1249-1291) 600
Synthesis, Application and Future Perspectives of Smart Nano-materials - Part 1 400
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8153492
求助须知:如何正确求助?哪些是违规求助? 9550166
关于积分的说明 21696892
捐赠科研通 7742051
什么是DOI,文献DOI怎么找? 3425502
关于科研通互助平台的介绍 2550620
邀请新用户注册赠送积分活动 2469156